Related Experiment Video
Updated: Aug 5, 2026

Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
Published on: May 23, 2016
Histopathological Myocardial Changes and CPV-2 DNA Detection in Young Dogs: A Retrospective Study
Adrian Stancu1, Janos Degi1, Iasmina Luca1
1Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I" from Timișoara, Calea Aradului 119, 300645 Timișoara, Romania.
Canine parvovirus type 2 (CPV-2) can cause heart damage in young dogs, with CPV-2 DNA found in dogs showing myocarditis, necrosis, and fibrosis. Further research is needed to confirm the direct link between CPV-2 and heart lesions.
Area of Science:
- Veterinary Pathology
- Canine Virology
- Cardiovascular Disease
Background:
- Canine parvovirus type 2 (CPV-2) is a major cause of illness and death in young dogs globally.
- While the enteric form of CPV-2 is well-understood, its impact on the heart (myocardium) is less clear.
Purpose of the Study:
- To investigate myocardial lesions in young dogs.
- To determine the association between CPV-2 DNA presence and observed heart lesions using histopathology and PCR on cardiac tissue.
Main Methods:
- Retrospective analysis of 27 young dogs (3-11 months) that underwent necropsy.
- Histopathological examination of heart tissue (H&E staining).
- Conventional PCR for CPV-2 DNA detection in formalin-fixed paraffin-embedded (FFPE) cardiac samples.
Main Results:
- All dogs (100%) exhibited myocardial abnormalities, primarily myocarditis.
- Cardiomyocyte necrosis and fibrosis were found in 33.3% and 51.9% of cases, respectively.
- CPV-2 DNA was detected in 33.3% of myocardial samples, with significantly higher rates of necrosis (77.8%) and fibrosis (100%) in these cases.
Conclusions:
- Detection of CPV-2 DNA in affected heart tissue suggests a potential link between CPV-2 infection and myocardial injury in young dogs.
- The study's retrospective nature and sample size limit definitive conclusions on causality.
- Further research with larger cohorts and advanced techniques is necessary to elucidate the pathogenesis and clinical significance of CPV-2-associated myocardial lesions.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

